We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Dragon
Careers
The shareholders of the Mimacom Flowable Group ("MFG") have sold MFG to the private equity investment house Ardian, accompanied by a reinvestment of the management. The transaction was completed on 19 April 2023. Headquartered in...
ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.
Intel Capital, a leading investor in the future of compute, has invested in UNISERS AG, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14m seed financing round was led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures.
Bachem Holding AG (SIX:BANB) has raised a total of CHF 108.1 million through an accelerated bookbuilding process by issuing 1,250,000 new shares at a placement price of CHF 86.50 per share to accelerate its growth plans.
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5m series A investment round of Nexoya AG, a Swiss marketing analytics start up.
CODE41 SA, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus SA and the opensource smart contract published by CMTA.
The German life science and medtech investor SHS Gesellschaft für Beteiligungsmanagement mbH has made a EUR 10 million investment in Simulands AG, a Zurich-based manufacturer of simulation devices for medical training of cardiovascular interventions.
The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland.
Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, based in Muttenz, Switzerland, has taken another major step to achieving its vision by closing a first tranche of its series B financing round raising CHF 8.5m from new and existing investors.
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative.
Displaying results 11 to 20 out of 154
